Although type 1 diabetic patients have low levels of hepatic insulin in comparison to type 2 diabetics, thereby favoring β oxidation, it is still controversial whether this protects [30] them against NAFLD. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.